Literature DB >> 2415976

Complexes of polyoma virus medium T antigen and cellular proteins.

T Grussenmeyer, K H Scheidtmann, M A Hutchinson, W Eckhart, G Walter.   

Abstract

Antibodies against synthetic peptides corresponding to the carboxyl-terminal six amino acids, Lys-Arg-Ser-Arg-His-Phe (KF), and an internal region, Glu-Glu-Glu-Glu-Tyr-Met-Pro-Met-Glu (EE), of polyoma virus medium T antigen were used successively to purify medium T antigen by affinity chromatography. Medium T antigen from cell extracts was first bound to anti-KF antibodies and released from the immune complex with excess KF peptide; then it was bound to anti-EE antibodies and released with excess EE peptide. Two proteins, pp60c-src and a new protein of approximately equal to 61,000 Da (61-kDa protein), were copurified because they formed complexes with medium T antigen. The 61-kDa protein-medium T antigen complex was detected in extracts from wild-type-infected and transformed cells but not from cells infected with NG59 virus, which has a mutation in the medium T gene and is transformation defective. Instead, NG59 medium T antigen formed a complex with another cellular protein of approximately equal to 72,000 Da.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2415976      PMCID: PMC390888          DOI: 10.1073/pnas.82.23.7952

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  18 in total

1.  Protein kinase activity associated with polyoma virus middle T antigen in vitro.

Authors:  A E Smith; R Smith; B Griffin; M Fried
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

2.  Tumor antigens induced by nontransforming mutants of polyoma virus.

Authors:  J Silver; B Schaffhausen; T Benjamin
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

3.  Comparison of phosphorylation of two polyoma virus middle T antigens in vivo and in vitro.

Authors:  B Schaffhausen; T L Benjamin
Journal:  J Virol       Date:  1981-10       Impact factor: 5.103

4.  Mutation causing premature termination of the polyoma virus medium T antigen blocks cell transformation.

Authors:  D Templeton; W Eckhart
Journal:  J Virol       Date:  1982-03       Impact factor: 5.103

5.  Identification of DNA sequence changes leading to loss of transforming ability in polyoma virus.

Authors:  G G Carmichael; T L Benjamin
Journal:  J Biol Chem       Date:  1980-01-10       Impact factor: 5.157

6.  An activity phosphorylating tyrosine in polyoma T antigen immunoprecipitates.

Authors:  W Eckhart; M A Hutchinson; T Hunter
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

7.  Phosphorylation of polyoma T antigens.

Authors:  B S Schaffhausen; T L Benjamin
Journal:  Cell       Date:  1979-12       Impact factor: 41.582

8.  Phosphorylation sites in enolase and lactate dehydrogenase utilized by tyrosine protein kinases in vivo and in vitro.

Authors:  J A Cooper; F S Esch; S S Taylor; T Hunter
Journal:  J Biol Chem       Date:  1984-06-25       Impact factor: 5.157

9.  Antibodies specific for the polyoma virus middle-size tumor antigen.

Authors:  G Walter; M A Hutchinson; T Hunter; W Eckhart
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

10.  Virus-specific proteins in the plasma membrane of cells lytically infected or transformed by pol-oma virus.

Authors:  Y Ito; J R Brocklehurst; R Dulbecco
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

View more
  89 in total

Review 1.  Natural biology of polyomavirus middle T antigen.

Authors:  K A Gottlieb; L P Villarreal
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

2.  The proapoptotic BH3-only protein bim is expressed in hematopoietic, epithelial, neuronal, and germ cells.

Authors:  L A O'Reilly; L Cullen; J Visvader; G J Lindeman; C Print; M L Bath; D C Huang; A Strasser
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

3.  The third subunit of protein phosphatase 2A (PP2A), a 55-kilodalton protein which is apparently substituted for by T antigens in complexes with the 36- and 63-kilodalton PP2A subunits, bears little resemblance to T antigens.

Authors:  D C Pallas; W Weller; S Jaspers; T B Miller; W S Lane; T M Roberts
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

4.  Characterization of the interaction of polyomavirus middle T antigen with type 2A protein phosphatase.

Authors:  E T Ulug; A J Cartwright; S A Courtneidge
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

5.  The early divisome protein FtsA interacts directly through its 1c subdomain with the cytoplasmic domain of the late divisome protein FtsN.

Authors:  Kimberly K Busiek; Jesus M Eraso; Yipeng Wang; William Margolin
Journal:  J Bacteriol       Date:  2012-02-10       Impact factor: 3.490

6.  Conversion of scFv peptide-binding specificity for crystal chaperone development.

Authors:  Jennifer C Pai; Jeffrey A Culver; Jason E Drury; Rakesh S Motani; Raquel L Lieberman; Jennifer A Maynard
Journal:  Protein Eng Des Sel       Date:  2011-01-08       Impact factor: 1.650

7.  Interactions between polyomavirus medium T antigen and three cellular proteins of 88, 61, and 37 kilodaltons.

Authors:  T Grussenmeyer; A Carbone-Wiley; K H Scheidtmann; G Walter
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

Review 8.  Protein phosphatases and DNA tumor viruses: transformation through the back door?

Authors:  M C Mumby; G Walter
Journal:  Cell Regul       Date:  1991-08

9.  Stoichiometry of cellular and viral components in the polyomavirus middle-T antigen-tyrosine kinase complex.

Authors:  S H Cheng; P C Espino; J Marshall; R Harvey; A E Smith
Journal:  Mol Cell Biol       Date:  1990-10       Impact factor: 4.272

10.  Mutation of a cysteine residue in polyomavirus middle T antigen abolishes interactions with protein phosphatase 2A, pp60c-src, and phosphatidylinositol-3 kinase, activation of c-fos expression, and cellular transformation.

Authors:  G M Glenn; W Eckhart
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.